language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
GRDNGRDN

$31.55

+0.30
arrow_drop_up0.96%
Current Market·update12 Nov 2025 21:00
Day's Range
29.8078-31.81
52-week Range
17.78-37.43

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-11-10
Next Earnings TimeAfter Market Close
Volume295.46K
Average Volume 30d350.92K

AI GRDN Summary

Powered by LiveAI
💰
-14.3
Valuation (P/E Ratio)
Negative P/E indicates net loss
📈
-1152.63
EPS Growth (YoY)
Significant negative earnings per share change
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
72

The company shows solid fundamental performance and positive thematic alignment, but current technical indicators suggest a need for caution due to potential overbought conditions. Long-term prospects appear favorable.

Moderate

Thematic

70

Guardian Pharmacy Services operates in the healthcare sector, with a focus on long-term care pharmacy services. The company's growth is tied to demographic trends in aging populations and the increasing demand for specialized pharmacy care.

Strong

Fundamental

77

Guardian Pharmacy Services demonstrates improving revenue and profitability over recent years, with a manageable debt level and positive free cash flow. However, recent quarterly performance shows a significant dip in net income.

Neutral

Technical

65

The stock is trading below key moving averages on a daily basis, indicating a bearish short-term trend. While some shorter timeframes show neutral or buy signals, the overall trend suggests caution.

FactorScore
Healthcare Demographics75
Pharmacy Services Market70
Technological Integration70
Regulatory Landscape65
FactorScore
Valuation40
Profitability35
Growth80
Balance Sheet Health85
Cash Flow70
FactorScore
Trend Analysis30
Momentum50
Support & Resistance65
Short-term Oscillators75
Short-term Moving Averages75

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (8)

Financial Health & Liquidity chevron_right

Strengthening Debt Position

Total debt decreased from $61.00M in Q4 2023 to $30.13M in Q4 2024, indicating a significant deleveraging effort and improved financial stability. The debt-to-equity ratio has improved, suggesting lower financial risk.

Growth and Profitability chevron_right

Revenue Growth Trend

Revenue has shown an upward trend, growing from $792.07M in 2021 to $1.23B in 2024, demonstrating consistent top-line expansion.

Show More 🔒
thumb_down

Bearish Points (9)

Earnings Performance chevron_right

Negative Net Income

The company reported a net loss of -$87.29M in 2024, indicating a lack of profitability. This is a significant concern for investors.

Growth and Profitability chevron_right

Declining Net Margin

The net margin has turned negative (-7.1% in 2024), compared to a positive 2.3% in 2023, signaling a deterioration in profitability and operational efficiency.

Show More 🔒

Calendar

August 2025

8

Next Earnings Date

EPS Est.
Revenue Est.

H: $0.22

A: $0.21

L: $0.21

H: 329.70M

A: 329.57M

L: 329.44M

Profile

Employees (FY)3.4K
ISINUS40145W1018
FIGI-

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Seasonals

Price Target

27.33 USD

The 39 analysts offering 1 year price forecasts for GRDN have a max estimate of 28.00 and a min estimate of 26.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
20.4M (89.91%)
Closely held shares
2.29M (10.09%)
22.7M
Free Float shares
20.4M (89.91%)
Closely held shares
2.29M (10.09%)

Capital Structure

Market cap
477.35M
Debt
30.13M
Minority interest
0.00
Cash & equivalents
4.66M
Enterprise value
502.82M

Valuation - Summary

Market Cap
1.33B
Net income
-91.2M(-6.86%)
Revenue
982M(73.87%)
1.33B
Market Cap
1.33B
Net income
-91.2M(-6.86%)
Revenue
982M(73.87%)
Price to earning ratio (P/E)-14.60x
Price to sales ratio (P/S)1.40x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
1.23B
COGS
984.04M
Gross Profit
244.37M
OpEx
307.29M
Operating Income
-62.92M
Other & Taxes
24.37M
Net Income
-87.29M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒